- Home
- HSCS vs PAVM Comparison
HSCS vs PAVM Comparison
Compare HSCS & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSCS
- PAVM
- Stock Information
- Founded
- HSCS 2007
- PAVM 2014
- Country
- HSCS United States
- PAVM United States
- Employees
- HSCS N/A
- PAVM N/A
- Industry
- HSCS Medical Specialities
- PAVM Medical/Dental Instruments
- Sector
- HSCS Health Care
- PAVM Health Care
- Exchange
- HSCS Nasdaq
- PAVM Nasdaq
- Market Cap
- HSCS 8.7M
- PAVM 8.0M
- IPO Year
- HSCS 2022
- PAVM 2016
- Fundamental
- Price
- HSCS $3.46
- PAVM $0.40
- Analyst Decision
- HSCS Strong Buy
- PAVM Strong Buy
- Analyst Count
- HSCS 2
- PAVM 1
- Target Price
- HSCS $13.00
- PAVM $19.00
- AVG Volume (30 Days)
- HSCS 87.4K
- PAVM 278.8K
- Earning Date
- HSCS 09-11-2025
- PAVM 11-12-2025
- Dividend Yield
- HSCS N/A
- PAVM N/A
- EPS Growth
- HSCS N/A
- PAVM N/A
- EPS
- HSCS N/A
- PAVM 0.83
- Revenue
- HSCS $6,250.00
- PAVM $1,020,000.00
- Revenue This Year
- HSCS $13,968.97
- PAVM N/A
- Revenue Next Year
- HSCS $166.67
- PAVM $455.63
- P/E Ratio
- HSCS N/A
- PAVM $0.49
- Revenue Growth
- HSCS N/A
- PAVM N/A
- 52 Week Low
- HSCS $2.52
- PAVM $0.30
- 52 Week High
- HSCS $6.47
- PAVM $1.77
- Technical
- Relative Strength Index (RSI)
- HSCS 50.77
- PAVM 37.31
- Support Level
- HSCS $3.00
- PAVM $0.39
- Resistance Level
- HSCS $3.70
- PAVM $0.45
- Average True Range (ATR)
- HSCS 0.21
- PAVM 0.04
- MACD
- HSCS 0.02
- PAVM -0.00
- Stochastic Oscillator
- HSCS 65.71
- PAVM 10.34
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.